单侧腋股旁路与交叉股股旁路治疗慢性肢体威胁性缺血的结局比较
本研究基于VQI-Medicare联动数据,经1:2倾向性评分匹配比较单侧腋股旁路(AxFB)与交叉股股旁路(FFB)治疗慢性肢体威胁性缺血(CLTI)的围术期及5年结局;AxFB围术期死亡率相当但并发症更高,5年总生存率更低,而无截肢生存与免再干预生存相似。
要点
- AxFB术后任何并发症(30% vs 15%)、同侧大截肢、院内再干预及手术部位感染均高于FFB。
- 5年AxFB总生存率更低(41% vs 46%;aHR 1.3,95%CI 1.0-1.7),免再干预生存相似。
核心结论
- 在CLTI患者中,单侧AxFB较FFB的5年总生存率更低,而免截肢生存与免再干预生存率相似。
- AxFB与FFB围术期死亡率相当,但AxFB术后并发症率更高。
- 在解剖外旁路选项中,FFB仍为一线治疗,单侧AxFB是特定CLTI患者可接受的替代选择。
研究设计与样本
- 回顾性队列研究,使用Vascular Quality Initiative与Medicare claim联动数据(2014–2019年)。
- 纳入非急诊单侧AxFB与FFB患者,排除同期其他旁路/干预。
- 共纳入1185例(AxFB占27%),经1:2倾向性评分匹配后为224例AxFB与374例FFB。
临床怎么用
- 在CLTI需解剖外旁路时,优先选择FFB作为一线方案。
- 单侧AxFB可用于无法耐受主动脉阻断或腹部条件差、且FFB不可行的特定CLTI患者,但需告知并发症与远期生存风险更高。
- AxFB术后应加强并发症监测与出院规划,因其并发症率、住院时长更高且出院回家率更低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In patients with chronic limb-threatening ischemia (CLTI), extra-anatomical bypasses are viable options to establish inflow when aortic cross-clamping necessary for anatomical reconstruction cannot be tolerated or in those with a hostile abdomen. Given their infrequent use, direct comparisons between unilateral axillofemoral bypass (AxFB) vs cross-over femorofemoral bypass (FFB) for CLTI remain scarce. We evaluated postoperative and 5-year outcomes after AxFB vs FFB for CLTI. METHODS: Patients undergoing nonemergent unilateral AxFB and FFB in the Vascular Quality Initiative linked to Medicare claims between 2014 and 2019 were identified, excluding procedures with other concomitant bypasses/interventions. We performed 1:2 (AxFB:FFB) propensity score matching for baseline demographics, comorbidities, urgency, ipsilateral presentation, and contralateral symptoms (rest pain vs ulcer/gangrene), and prior interventions/bypass procedures. Perioperative and 5-year outcomes were analyzed using logistic regression and Cox regression models. RESULTS: We included 1185 patients (27% AxFB), of whom 224 AxFBs matched with 374 FFBs. After matching, perioperative mortality was comparable between the AxFB and FFB bypass groups (15% vs 10%; P = .12). However, AxFB patients had higher rates of any postoperative complication (30% vs 15%; P < .01) as well as ipsilateral major amputations (below knee, 1.8% vs 0.5%; above knee, 5.4% vs 2.4%; P = .05), in-hospital reintervention (13% vs 7.2%; P = .04), and surgical site infections (5.8% vs 1.6%; P = .01). Patency rates at discharge were similar between the two groups. Postoperative length of stay was higher in the AxFB patients (6.9 ± 5.3 vs 6.2 ± 20; P < .01), and rates for discharge to home were lower (57% vs 68%; P = .07). At 5 years, AxFB was associated with lower rates of 5-year overall survival (41% vs 46%; adjusted hazard ratio [aHR]. 1.3; 95% confidence interval [CI], 1.0-1.7; P = .046), and comparable reintervention free survival (49% vs 45%; aHR, 0.86; 95% CI, 0.59-1.2; P = .40). There was a suggestion of lower major amputation-free survival (69% vs 89%; aHR, 1.7; 95% CI, 0.92-3.1; P = .089), albeit not significantly. CONCLUSIONS: Unilateral AxFB for CLTI was associated with lower 5-year survival rates and similar amputation-free survival and reintervention free-survival rates, alongside similar perioperative mortality and higher postoperative complication rates when compared with FFB. Our data confirm that, among the extra-anatomical bypass options, FFB remains first-line therapy and unilateral AxFB is an alternative option for the treatment of aortoiliac occlusive disease in select CLTI patients with acceptable outcomes.
引用
- Yadavalli SD, Caron E, Colome D, et al. Outcomes following unilateral axillofemoral bypass versus crossover femorofemoral bypass in chronic limb-threatening ischemia patients. J Vasc Surg. 2025. PMID: 41167384. doi:10.1016/j.jvs.2025.10.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。